FORT WAYNE MEDICAL ONCOLOGY AND HEMATOLOGY
| Site name: | Fort Wayne Medical Oncology and Hematology | Active Prostate Cancer Clinical Trials: | |
| Contact: | Sreenivasa R. Nattam, MD | That match your search: | No search performed |
| Phone: | 260-484-8830 | ||
| Site email: | Not Provided |
3
Active Prostate Cancer Clinical Trials at Fort Wayne Medical Oncology and Hematology:
| TRIAL ID | TITLE | TRIAL PHASE |
|---|---|---|
| NCT00309985 | CHAARTED: ChemoHormonal Therapy Versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer [CHAARTED] | Phase 3 |
| NCT01267266 | A Randomized Discontinuation Phase 2 Study of AZD0530 as a Metastasis Inhibitor in Castrate Resistant Prostate Cancer | Phase 2 |
| NCT01260688 | A Phase 2 Randomized Study of Cediranib (AZD2171) Alone Compared With the Combination of Cediranib (AZD2171) Plus BMS-354825 (Dasatinib, Sprycel) in Docetaxel Resistant, Castration Resistant Prostate Cancer | Phase 2 |